Immunovia AB (publ)
IMMNOV SE0006091997
ICB 2010 : Health Care / Health CareAnnual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -42% | -66% | -93% | -78% | -9% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Michael Lofman DIR |
2.20 SEK |
587,532 Sold |
1,292,570 SEK |
06/01/2024 | 03/01/2024 |
| Jeffrey Borcherding CEO |
0.18 USD |
350,000 Bought |
61,810 USD |
08/06/2023 | 07/06/2023 |
| Hans Johansson DIR |
6.70 SEK |
14,924 Bought |
99,991 SEK |
28/04/2023 | 06/04/2023 |
| Peter Andersen DIR |
31.00 SEK |
6,000 Bought |
186,000 SEK |
23/02/2022 | 22/02/2022 |
| Martin Moeller DIR |
133.80 SEK |
1,056 Bought |
141,293 SEK |
03/09/2021 | 02/09/2021 |
| Patrik Dahlen CEO |
98.54 SEK |
6,860 Bought |
675,984 SEK |
28/05/2021 | 28/05/2021 |
| Peter Andersen DIR |
109.00 SEK |
2,730 Bought |
297,570 SEK |
11/05/2021 | 07/05/2021 |
| Hans Johansson DIR |
113.00 SEK |
1,700 Bought |
192,100 SEK |
03/05/2021 | 03/05/2021 |
| Peter Andersen DIR |
114.00 SEK |
1,500 Bought |
171,000 SEK |
03/05/2021 | 30/04/2021 |
| Mimmi Ekberg DIR |
119.13 SEK |
451 Bought |
53,728 SEK |
02/12/2020 | 02/12/2020 |